Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Innate ends work on NK cell engager in phase 1/2 trial as part of ongoing pipeline refocus

Innate ends work on NK cell engager in phase 1/2 trial as part of ongoing pipeline refocus

  • March 26, 2026

Innate Pharma has finally called time on a NK cell engager in phase 1/2 development as part of an ongoing fine-tuning of the French biotech’s pipeline.

Leave A Comment

Fields (*) Mark are Required